Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FDA approves new drug for sickle cell disease

      FDA approves new drug for sickle cell disease

      Ruby Khatun Khatun10 July 2017 11:45 AM IST
      The U.S. Food and Drug Administration approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to...
      Omega Healthcare to hire 1,000 people in 6 months

      Omega Healthcare to hire 1,000 people in 6 months

      Ruby Khatun Khatun10 July 2017 10:30 AM IST
      Mumbai: Technology-driven healthcare outsourcing services provider Omega Healthcare Management Services plans to hire 1,000 persons at the Bengaluru...
      Shire gets injunction against Roche over hemophilia drug

      Shire gets injunction against Roche over hemophilia drug

      Ruby Khatun Khatun10 July 2017 10:05 AM IST
      ZURICH: Pharmaceutical group Shire said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche over its hemophilia...
      Glenmark Pharma gets USFDA nod for hypertension medicine

      Glenmark Pharma gets USFDA nod for hypertension medicine

      Ruby Khatun Khatun9 July 2017 10:20 AM IST
      New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Amlodipine and Olmesartan Medoxomil tablets, used in...
      Midmark sets up medical device manufacturing plant in Gujarat

      Midmark sets up medical device manufacturing plant in Gujarat

      Ruby Khatun Khatun9 July 2017 10:00 AM IST
      Mumbai: Midmark India, a provider of medical, dental and veterinary equipment solutions, inaugurated the country's first nano technology-based medical...
      FDA Approves VNS Therapy Treatment for Drug-Resistant Epilepsy in young Children

      FDA Approves VNS Therapy Treatment for Drug-Resistant Epilepsy in young Children

      Ruby Khatun Khatun9 July 2017 9:15 AM IST
      LONDON: LivaNova PLC (“LivaNova” , medical technology company, announced it received FDA approval of its VNS Therapy® system (“VNS Therapy”) in...
      Pharma sector supply chain coping well after GST rollout:  Kiran Mazumdar Shaw

      Pharma sector supply chain coping well after GST rollout: Kiran Mazumdar Shaw

      Ruby Khatun Khatun8 July 2017 10:28 AM IST
      Mumbai: With the implementation of the Goods and Services Tax (GST) system from July 1, most of the supply chain in pharmaceuticals sector seems to...
      Drug generic name prescription likely to hit companies profit: ICRA

      Drug generic name prescription likely to hit companies profit: ICRA

      Ruby Khatun Khatun8 July 2017 9:34 AM IST
      Mumbai: The recent move by the government to ask doctors to prescribe drug generic name may lead to 5-10 per cent drop in value of the Indian pharma...
      FDA puts hold on Merck multiple myeloma trials after deaths

      FDA puts hold on Merck multiple myeloma trials after deaths

      Ruby Khatun Khatun8 July 2017 9:28 AM IST
      Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its...
      Novo Nordisk recalls faulty cartridge holders in insulin pens

      Novo Nordisk recalls faulty cartridge holders in insulin pens

      Ruby Khatun Khatun8 July 2017 9:00 AM IST
      Danish drugmaker Novo Nordisk said on Wednesday it was initiating a recall of insulin cartridge holders used in some NovoPen Echo insulin pen devices...
      Dr Agarwals Healthcare raises Rs 160 crore from Edelweiss fund for expansion

      Dr Agarwal's Healthcare raises Rs 160 crore from Edelweiss fund for expansion

      Ruby Khatun Khatun7 July 2017 1:28 PM IST
      New Delhi: Eye care chain Dr Agarwal's Healthcare has raised Rs 160 crore from Edelweiss Special Opportunities Fund (ESOF) II to be used for its...
      Sanofi, Regeneron gets EU approval to market Rheumatoid Arthritis drug Kevzara

      Sanofi, Regeneron gets EU approval to market Rheumatoid Arthritis drug Kevzara

      Ruby Khatun Khatun7 July 2017 1:24 PM IST
      Sanofi and Regeneron Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok